Survival analysis of patients with advanced non‐small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi‐center retrospective study

por Shi, Qingming, Guan, Maojing, Wang, Yong, Xu, Congjing, Tang, Lei, Fu, Wenhua, Bi, Minghong, Sun, Xiang, Gu, Kangsheng, Pang, Dongsheng
Publicado en Thorac Cancer (2017)